Featured Research Sessions
Monday, July 27, 2020: 8:30 AM – 9:30 AM Microbiome in Alzheimer’s Disease: Pathogenesis and Treatment Implications [SFRS1-02 Virtual Room Name: The Hague] Speakers: Dr. Meiyu Geng, Sam Sisodia, Michael Heneka, Bruce Lamb
Monday, July 27, 2020: 8:30 AM – 8:55 AM Functionalizing Genetic Variants in Alzheimer’s Disease [SCR1-11 Virtual Room Name: Session Chatroom B] Organizers: Greg Carter, Andy Saykin Speakers: Allison Goate, Karen Duff, Thomas Wingo, Mike Sasner
Posters
Monday, July 27, 2020
- 45981_Deep phenotyping of the 5XFAD model-IU-JAX-Pitt-MODEL-AD Center
- 36468_UCI_AAIC 2020_Poster 5xFAD
- 41491_Pharmacokinetic, Pharmacodynamics, and Transcriptomics Analysis of Verubecestat Treatment in 5XFAD mice
- 41531_Neurovascular Uncoupling of cerebral blood flow and glucose metabolism in APOE4, TREM2, and APOE4.TREM2 mice
- 45162 Hallmarks of Late-Onset Alzheimer’s Disease in a Humanized Mouse Model 45162 Hallmarks of LOAD
- 45390_Transcriptomic Profiling of APOE4Trem2R47H Mouse Models for Late Onset Alzheimer’s Disease
- 46575_AsliUyar_N-of-1-pathways transcriptomic analysis reveals distinct subtypes of Alzheimer’s Disease
- 40529_Translating genetic risk variants in disease-associated enhancers into novel mouse models of Alzheimer’s disease
- 40548 Lifespan neuroimaging of the 5XFAD mouse model of Alzheimer’s Disease: Evolution of metabolic and vascular perturbations 40548_AAIC Szu 2020 072020 Final
- 43355 Lifespan diffusion MRI reveals regional abnormalities in the 5XFAD model of Alzheimer’s Disease AAIC 2020 Jullienne 070320ao
- 41664_OlayanR_Transcriptomic profiling of diverse mouse strains identifies sex-specific Alzheimer’s-related pathway modifications
- 42019_Natural_Genetic_Variation_Alters_Alzheimer’s-related_Gene_Expression_Modules_in_Mice
Wednesday, July 29, 2020
- The IUSM-Purdue Alzheimer’s Disease Drug Discovery Center: A member of the NIH-Funded TREAT-AD Consortium. [#41107]